Market revenue in 2023 | USD 522.3 million |
Market revenue in 2030 | USD 922.8 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 49.95% in 2023. Horizon Databook has segmented the Germany interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
In Germany, the market for interventional devices is influenced by increasing product launches and developments by local & global manufacturers, such as Boston Scientific, B. Braun, and Abbott. For instance, in March 2021, B. Braun Interventional Systems (BIS) collaborated with Infraredx on a study trial for the B. Braun (Germany) SeQuent Please ReX.
In Germany, the Federal Joint Committee (G-BA) is responsible for making decisions on the reimbursement of medical devices. The G-BA evaluates the clinical and economic evidence for interventional cardiology devices and establishes the reimbursement rates for statutory health insurance providers.
Angioplasty stenting done by bare metal stents is exclusively reimbursed via the Diagnosisrelated Group (DRG) in the country. The reimbursement rates are based on the German Medical Association fee schedule and the Federal Ministry of Health's pricing agreements with manufacturers.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Germany interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account